Hepatitis C direct‐acting antiviral outcomes in patients 75 years and older-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Hepatitis C direct‐acting antiviral outcomes in patients 75 years and older

Published:2020-12-18 Issue:2 Volume:5 Page:253-257
ISSN:2397-9070
Container-title:JGH Open
language:en
Short-container-title:JGH Open

Author:

Parmar Parmvir¹²,Shafran Stephen D³,Borgia Sergio M⁴,Doucette Karen³,Cooper Curtis L¹²^ORCID

Affiliation:

1. Department of Medicine University of Ottawa Ottawa Ontario Canada

2. The Ottawa Hospital Research Institute Ottawa Ontario Canada

3. Department of Medicine University of Alberta Edmonton Alberta Canada

4. William Osler Health Centre Brampton Civic Hospital Brampton Ontario Canada

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jgh3.12480

Reference27 articles.

1. Burden of Hepatitis C Virus Infection Among Older Adults in Long-Term Care Settings: a Systematic Review of the Literature and Meta-Analysis

2. Treating hepatitis C in the elderly: pharmacotherapeutic considerations and developments

3. Hepatitis C Virus Infection in the Elderly

4. Safety and efficacy of glecaprevir/pibrentasvir for the treatment of chronic hepatitis C in patients aged 65 years or older

5. Chronic hepatitis C infection in the elderly

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Personalized care approaches to hepatitis C therapy: recent advances and future directions;Expert Review of Anti-infective Therapy;2024-03-11

2. Evidence for the elimination of viral hepatitis B and C in Egypt: Results of a nationwide survey in 2022;Liver International;2024-01-30

3. Hematological and Biochemical Changes after Anti-Hepatitis C Virus Therapy in Older Patients;INT J GERONTOL;2024

4. Sofosbuvir‐based therapies in genotype 2 hepatitis C virus cirrhosis: A real‐life experience with focus on ribavirin dose;Pharmacology Research & Perspectives;2021-06-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3